SCHEMBL5129093

SCHEMBL5129093

Cc1cc2nc3c(=O)n(CC(=O)Oc4c(F)c(F)c(F)c(F)c4F)c(=O)nc-3n(C)c2cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 9/20 0.42
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ TDP2 O95551 1/20 0.34
▸ NGF P01138 1/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ HAT1 O14929 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14176780 0.88 GSR (0.45) GSRKDM4EALDH1A1MEN1KMT2A
SCHEMBL14176774 0.82 GSR (0.51) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL29375626 0.82 GSR (0.51) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL14212581 0.74 KDM4E (0.48) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL14399199 0.73 SMN1; SMN2 (0.58) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL14176773 0.68 GSR (0.40) GSRKDM4EMEN1KMT2AMAPT
SCHEMBL6266889 0.67 SLC9A1 (0.52) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL14369939 0.67 KDM4E (0.51) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL15908041 0.67 MEN1 (0.43) GSRKDM4EALDH1A1GLAHPGD
SCHEMBL20155597 0.67 GSR (0.48) GSRKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138817-A1 Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same CREDIA JAPAN CO., LTD. (JP) 2008-06-12 — — US disclosed
US-7282575-B2 Functional peptide nucleic acid monomer and process for producing the same CREDIA JAPAN CO., LTD. (JP) 2007-10-16 — — US disclosed
US-7282575-B2 Functional peptide nucleic acid monomer and process for producing the same CREDIA JAPAN CO., LTD. (JP) 2007-10-16 — — US disclosed
US-7282575-B2 Functional peptide nucleic acid monomer and process for producing the same CREDIA JAPAN CO., LTD. (JP) 2007-10-16 — — US disclosed
US-20040101839-A1 Novel functional peptide nucleic acid monomer and process for producing the same CREDIA JAPAN CO., LTD. (JP) 2004-05-27 — — US disclosed
EP-1357112-A1 NOVEL FUNCTIONAL PEPTIDE NUCLEIC ACID MONOMER AND PROCESS FOR PRODUCING THE SAME Applied Biosystems Japan Ltd. (JP) 2003-10-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040101839-A1 Novel functional peptide nucleic acid monomer and process for producing the same NSUN3, NSUN2, RNGTT GSR 4619/4885KDM4E 4095/4885ALDH1A1 4824/4885
US-20080138817-A1 Novel Functional Peptide Nucleic Acid Monomer and Process for Producing the Same NSUN3, RNGTT, NSUN2 GSR 4237/4885KDM4E 4577/4885ALDH1A1 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback